Clinical Trials Browser

Phase 2 × Melanoma × Interleukin-12 × Clear all

NCT00026143 2013-06-05

Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

Phase 2 Completed

Melanoma